 SAN DIEGO, June 03, 2022 GLOBE NEWSWIRE -- Fate Therapeutics, Inc. the Company or Fate Therapeutics NASDAQ: FATE, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the Company will present at the 2022 Jefferies Global Healthcare Conference on Friday, June 10, 2022 at 9:00 AM ET in New York, New York. 